|
PMID
|
Match String
|
Actual String
|
Score
|
Flanking text
|
Edited by
|
Edit
|
| 17582695 | VIP | VIP | 2.2 | vasoactive neuropeptides (VNs) VNs such as vasoactive intestinal peptide (VIP) VIP and pituitary adenylate cyclase activating polypeptide (PACAP) PACAP has been | |  |
| 17582695 | VIP | VIP | 2.2 | vasoactive neuropeptides (VNs) VNs such as vasoactive intestinal peptide (VIP) VIP and pituitary adenylate cyclase activating polypeptide (PACAP) PACAP has been | | |
| 17582695 | VIP | VIP | 2.2 | however in a series of ALS patients CSF levels of VIP were found to be significantly lower compared with controls 52 | | |
| 17582695 | VIP | VIP | 2.2 | VIP has demonstrated potent effects on neurite outgrowth in spinal cord | | |
| 17582695 | VIP | VIP | 2.2 | Interestingly Sun et al 54 noted impaired VIP receptor (VPAC2) VPAC2 production in activated T cells in MS | | |
| 17582695 | VIP | VIP | 2.2 | finding may be extremely important as more widespread impairment of VIP if proven in patients with MS may explain the complete | | |
| 17582695 | VIP | VIP | 2.2 | Similarly VIP may have a role in MS treatment 58 | | |
| 17582695 | vasoactive intestinal peptide | vasoactive intestinal peptide | 1.0 | autoimmune dysfunction of endogenous vasoactive neuropeptides vns such as vasoactive intestinal peptide vip and pituitary adenylate cyclase activating polypeptide pacap has been postulated as a cause for some fatigue related conditions. | | |
| 17582695 | vasoactive intestinal peptide | vasoactive intestinal peptide | 1.0 | autoimmune dysfunction of endogenous vasoactive neuropeptides vns such as vasoactive intestinal peptide vip and pituitary adenylate cyclase activating polypeptide pacap has been postulated as a cause for some fatigue related conditions. | | |